Advertisement

Medicamenteuze behandeling van afasie

mei 2003
  • H.F.M Peters
  • R. Bastiaanse
  • J. Van Borsel
  • P.H.O. Dejonckere
  • K. Jansonius-Schultheiss
  • Sj. Van der Meulen
  • B.J.E. Mondelaers

Samenvatting

Vasculaire aandoeningen van het centrale zenuwstelsel veroorzaken vaak niet alleen zware fysieke maar ook ernstige cognitieve handicaps.

Literatuur

  1. Albert, M.L., Bachman, D., Morgan, A., & Helm-Estabrooks, N. (1988). Pharmacotherapy for aphasia. Neurology, 38, 877-879.Google Scholar
  2. Bachman, D., & Morgan, A. (1988). The role of pharmacotherapy in the treatment of aphasia: preliminary results. Aphasiology, 2, 225-228.Google Scholar
  3. Bergmann, P.S., & Green, M. (1951). Aphasia: effect of intravenous sodium amytal. Neurology, 1, 471-475.Google Scholar
  4. Billow, B.W. (1949). Observation of the use of sodium amytal in the treatment of aphasia. Medical Record, 162, 12-13.Google Scholar
  5. Bragoni, M., Altieri, M., Di Piero, V., Padovani, A., Mostardini, C., & Lenzi, G.I. (2000). Bromocriptine and speech therapie in non-fluent chronic aphasia after stroke. Neurological Sciences, 21, 19-22.Google Scholar
  6. Clark, A.N.G., & Mankikar, G.D. (1979). d-Amphetamine in elderly patients refractory to rehabilitation procedures. Journal of the American Geriatric Society, 27, 174-177.Google Scholar
  7. Crisostomo, E.A., Duncan, P.W., & Dawson, D.V. (1988). Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Annals of Neurology, 23, 94-97.Google Scholar
  8. Darley, F.L., Keith, R.L., & Susanuma, S. (1977). The effect of alerting and tranquilizing drugs upon the performance of aphasic patients. Clinical Aphasiology, 7, 91-96.Google Scholar
  9. De Deyn, P.P., De Reuck, J.D., Deberdt, W., Vlietinck, R., & Orgogozo, J.M. (1997). Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (pass) Group. Stroke, 28, 2347-2352.Google Scholar
  10. Enderby, P., Broeckx, J., Hospers, W., Schildermans, F., & Deberdt, W. (1994). Effect of Piracetam on recovery and rehabilitation after stroke: a double-blind, placebo controlled study. Clinical Neuropharmacology, 17, 320-331.Google Scholar
  11. Freedman, M., Alexander, M.P., & Naeser, M.A. (1984). Anatomic basis of transcortical motor aphasia. Neurology, 34, 409-417.Google Scholar
  12. Gold, M., VanDam, D., & Silliman, E.R. (2000). An open-label trial of bromocriptine in nonfluent aphasia: a qualitative analysis of word storage and retrieval. Brain and Language, 74, 141-156.Google Scholar
  13. Gupta, S.R., & Mlcoch, A.G. (1992). Bromocriptine treatment of nonfluent aphasia. Archives of Physical and Medical Rehabilitation, 73, 373-376.Google Scholar
  14. Hassid, E.J. (1995). Neuropharmacological therapy and motor recovery after stroke. Military Medicine, 160, 223-226.Google Scholar
  15. Hemphill, D.E. (1951). Restoration of speech in severe aphasia by intravenous and oral Priscol. British Medical Journal, 2, 891-892.Google Scholar
  16. Herrschaft, H. (1988). Die Wirksamkeit von Piracetam bei der akuten zerebralen Ischämie des Mensches. Klinisch kontrollierte Doppelblindstudie Piracetam/10% Dextran 40 versus Dextran 40/ placebo. Medizinische Klinik, 83, 667-677.Google Scholar
  17. Huber, W. (1999). The role of piracetam in the treatment of acute and chronic aphasia. Pharmacopsychiatry, 32, 38-43.Google Scholar
  18. Huber, W., Willmes, K., Poeck, K., Van Vleymen, B., & Deberdt, W. (1997). Piracetam as an adjunct to language therapy for aphasia: arandomized double-blind placebo-controlled pilot study. Archives of Physical Medicine and Rehabilitation, 78, 245-250.Google Scholar
  19. Kessler, J., Thiel, A., Karbe, H., & Heiss, W.D. (2000). Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke, 31, 2112-2116.Google Scholar
  20. Leys, D., & Pruvo, J.P. (2002). Stratégie pratique en urgence face à un accident vasculaire cérébral. Encycl Méd Chir, Neurologie, 17-046-A-50.Google Scholar
  21. Linn, L. (1947). Sodium amytal in treatment of aphasia. Archives of Neurology and Psychiatry, 58, 357-358.Google Scholar
  22. MacLellan, E.L., Nicholas, L.E., Morley, G.K., & Brookshire, R.H. (1991). The effects of bromocriptine on speech and language function in a man with transcortical motor aphasia. Clinical Aphasiology, 20, 145-156.Google Scholar
  23. Ozeren, A., Sarica, Y., Mavi, H., & Demirkiran, M. (1995). Bromocriptine is ineffective in the treatment of chronic nonfluent aphasia. Acta Neurologica Belgica, 95, 235-238.Google Scholar
  24. Porch, B.E. (1981). The Porch Index of Communicative Ability. Palo Alto, CA: Consulting Psychologists Press.Google Scholar
  25. Raymer, A.M., Bandy, D., Adair, J.C., Schwartz, R.L., Williamson, D.J.G., Gonzalez Rothi, L.J., & Heilman, K.M. (2001). Effects of bromocriptine in a patient with crossed nonfluent aphasia: a case report. Archives of physical and Medical Rehabilitarion, 82, 139-144.Google Scholar
  26. Sabe, L., Leiguarda, R., & Starkstein, S. {1992). An open-label trial ofbromocriptine in nonfluent aphasia. Neurology, 42,1637-1638.Google Scholar
  27. Sabe, L., Salvarezza, G., Cuerva, A.G., Leiguarda, R., & Starkstein, S. ( 1995). A randomized, double-blind, placebo-controlled study of bromocriptine in nonfluent aphasia. Neurology, 45,2272-2274.Google Scholar
  28. Samo, M.T., Samo, J.E., & DilIer, L. (1972). The effect of hyperbatic oxygen on communication function in adults with aphasia secondary to stroke. Journal of Speech andHearing Research, 15,42-48.Google Scholar
  29. Small, S.L. ( 1994). Pharmacotherapy of aphasia: a ctitical review. Stroke, 25,1282-1289.Google Scholar
  30. Smith, S., & Thurton, E.C. (1951). Restoration of speech in severe aphasia by intravenous and oral Priscol. British Medical Journal, 891-892.Google Scholar
  31. Stolyarova, L., Kadykov,A., Kistenev, B., Varakin, Y., Yurchenko,A., Davydov, V., & Volkov, V. ( 1978). The role of Piracetam in complex rehabilitation therapy of patients with residual rnanifestations of a cerebral stroke. In EA. Babayan, N.V. Lebedeva, G.M. Rudenko, & N .K. Shagako (eds.). Nootropil in neurological and psychiatric pracrice: materia!s of a symposium. Moscow, 26 May.Google Scholar
  32. The Multicenter Acute Stroke Ttial-Europe Study Group. ( 1996). Thrombolytic therapy with streptokinase in acute ischemic stroke. New England Journal of Medicine, 335, 145-150.Google Scholar
  33. The National Institute of Neurological Disorders and Stroke rt-PA Study Group. (1995). Tissue plasminogen activator for acute ischernic stroke. New England Journal of Medicine, 333,1581-1587.Google Scholar
  34. Walker-Batson, D., Unwin, H., Curtis, S., Allen, E., Wood, M., Srnith, P., Devous, M.D., Reynolds, S., & Greenlee, R.G. (1992). Use of amphetamine in t:he treátrnent of aphasia. Restorarive Neurology and Neuroscience, 4, 47-50.Google Scholar
  35. West, R., & Stockel, S. ( 1965). The effect of meprobarnate on recovery from aphasia. Journal of Speech and Hearing Research, 8, 57-62.Google Scholar

Copyright information

© Bohn Stafleu van Loghum, onderdeel van Springer Media 2014

Authors and Affiliations

  • H.F.M Peters
  • R. Bastiaanse
  • J. Van Borsel
  • P.H.O. Dejonckere
  • K. Jansonius-Schultheiss
  • Sj. Van der Meulen
  • B.J.E. Mondelaers

There are no affiliations available

Personalised recommendations